Tarsus Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phas…

Biotechnology
US, Irvine [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Tarsus Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of TARS's Analysis
CIK: 1819790 CUSIP: 87650L103 ISIN: US87650L1035 LEI: - UEI: -
Secondary Listings
TARS has no secondary listings inside our databases.